Volonté C - Search Results

1

Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.

Apolloni S, Amadio S, Montilli C, Volonté C, D'Ambrosi N. Apolloni S, et al. Among authors: volonte c. Hum Mol Genet. 2013 Oct 15;22(20):4102-16. doi: 10.1093/hmg/ddt259. Epub 2013 Jun 4. Hum Mol Genet. 2013. PMID: 23736299

2

The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.

D'Ambrosi N, Finocchi P, Apolloni S, Cozzolino M, Ferri A, Padovano V, Pietrini G, Carrì MT, Volonté C. D'Ambrosi N, et al. Among authors: volonte c. J Immunol. 2009 Oct 1;183(7):4648-56. doi: 10.4049/jimmunol.0901212. Epub 2009 Sep 4. J Immunol. 2009. PMID: 19734218

3

The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.

Apolloni S, Parisi C, Pesaresi MG, Rossi S, Carrì MT, Cozzolino M, Volonté C, D'Ambrosi N. Apolloni S, et al. Among authors: volonte c. J Immunol. 2013 May 15;190(10):5187-95. doi: 10.4049/jimmunol.1203262. Epub 2013 Apr 15. J Immunol. 2013. PMID: 23589615

4

Dysregulated microRNAs in amyotrophic lateral sclerosis microglia modulate genes linked to neuroinflammation.

Parisi C, Arisi I, D'Ambrosi N, Storti AE, Brandi R, D'Onofrio M, Volonté C. Parisi C, et al. Among authors: volonte c. Cell Death Dis. 2013 Dec 12;4(12):e959. doi: 10.1038/cddis.2013.491. Cell Death Dis. 2013. PMID: 24336079 Free PMC article.

5

Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.

Apolloni S, Amadio S, Parisi C, Matteucci A, Potenza RL, Armida M, Popoli P, D'Ambrosi N, Volonté C. Apolloni S, et al. Among authors: volonte c. Dis Model Mech. 2014 Sep;7(9):1101-9. doi: 10.1242/dmm.017038. Epub 2014 Jul 18. Dis Model Mech. 2014. PMID: 25038061 Free PMC article.

6

Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.

Apolloni S, Fabbrizio P, Parisi C, Amadio S, Volonté C. Apolloni S, et al. Among authors: volonte c. Mol Neurobiol. 2016 Jan;53(1):518-531. doi: 10.1007/s12035-014-9019-8. Epub 2014 Dec 9. Mol Neurobiol. 2016. PMID: 25482048

7

New kid on the block: does histamine get along with inflammation in amyotrophic lateral sclerosis?

Volonté C, Parisi C, Apolloni S. Volonté C, et al. CNS Neurol Disord Drug Targets. 2015;14(5):677-86. doi: 10.2174/1871527314666150225143921. CNS Neurol Disord Drug Targets. 2015. PMID: 25714965 Review.

8

Purinergic contribution to amyotrophic lateral sclerosis.

Volonté C, Apolloni S, Parisi C, Amadio S. Volonté C, et al. Neuropharmacology. 2016 May;104:180-93. doi: 10.1016/j.neuropharm.2015.10.026. Epub 2015 Oct 26. Neuropharmacology. 2016. PMID: 26514402 Review.

9

Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.

Apolloni S, Fabbrizio P, Amadio S, Volonté C. Apolloni S, et al. Among authors: volonte c. J Neuroinflammation. 2016 Aug 22;13(1):191. doi: 10.1186/s12974-016-0658-8. J Neuroinflammation. 2016. PMID: 27549088 Free PMC article.

10

Histamine beyond its effects on allergy: Potential therapeutic benefits for the treatment of Amyotrophic Lateral Sclerosis (ALS).

Volonté C, Apolloni S, Sabatelli M. Volonté C, et al. Pharmacol Ther. 2019 Oct;202:120-131. doi: 10.1016/j.pharmthera.2019.06.006. Epub 2019 Jun 22. Pharmacol Ther. 2019. PMID: 31233766 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results